The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

• DOI: 10.1111/all.13397
• Publication Date: 2018-01-16T04:42:45Z
• Authors: T. Zuberbier; W. Aberer; R. Asero; A. H. Abdul Latiff; D. Baker; B. Ballmer‐Weber; J. A. Bernstein; C. Bindslev‐Jensen; Z. Brzoza; R. Buense Bedrikow; G. W. Canonica; M. K. Church; T. Craig; I. V. Danilycheva; C. Dressler; L. F. Ensina; A. Giménez‐Arnau; K. Godse; M. Gonçalo; C. Grattan; J. Hebert; M. Hide; A. Kaplan; A. Kapp; C. H. Katelaris; E. Kocatürk; K. Kulthanan; D. Larenas‐Linnemann; T. A. Leslie; M. Magerl; P. Mathelier‐Fusade; R. Y. Meshkova; M. Metz; A. Nast; E. Nettis; H. Oude‐Elberink; S. Rosumeck; S. S. Saini; M. Sánchez‐Borges; P. Schmid‐Grendel...; P. Staubach; G. Sussman; E. Toubi; G. A. Vena; C. Vestergaard; B. Wedi; R. N. Werner; Z. Zhao; M. Maurer
• Keywords: Guideline

Abstract This evidence‐ and consensus‐based guideline was developed following the methods recommended by Cochrane Grading of Recommendations Assessment, Development Evaluation ( GRADE ) working group. The conference held on 1 December 2016. It is a joint initiative Dermatology Section European Academy Allergology Clinical Immunology EAACI ), EU ‐founded network excellence, Global Allergy Asthma Network GA ² LEN Forum EDF World Organization WAO with participation 48 delegates 42 national international societies. acknowledged accepted Union Medical Specialists UEMS ). Urticaria frequent, mast cell‐driven disease, presenting wheals, angioedema, or both. lifetime prevalence for acute urticaria approximately 20%. Chronic spontaneous other chronic forms are disabling, impair quality life affect performance at work school. covers definition classification urticaria, taking into account recent progress in identifying its causes, eliciting factors pathomechanisms. In addition, it outlines evidence‐based diagnostic therapeutic approaches different subtypes urticaria.